[6] Use on inflamed, infected, or wounded scalp areas may increase irritation risk and is typically deferred until integument integrity is restored
An enzyme called NNMT (nicotinamide N-methyltransferase) drains the NAD+ salvage pathway by methylating nicotinamide, one of NAD+'s precursors
Common symptoms include fatigue, weakness, anemia, numbness or tingling, and difficulty thinking
These peptides require reconstitution and are packaged in 5mg vials, making them suitable for precise research applications
Research Combinations Discussed in the Literature AOD-9604 is sometimes discussed alongside Tesamorelin or BPC-157 in research contexts, but the rationale behind pairing these compounds is mechanistic complementarity, not a validated combination protocol no published clinical trial has tested AOD-9604 combined with either compound